Home
>
National Drug Code (NDC)
>
Budesonide
Budesonide - 0378-7155-01 - (budesonide)
Drug Information of Budesonide
| Product NDC: | 0378-7155 |
| Proprietary Name: | Budesonide |
| Non Proprietary Name: | budesonide |
| Active Ingredient(s): | 3 mg/1 & nbsp; budesonide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Budesonide
| Product NDC: | 0378-7155 |
| Labeler Name: | Mylan Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090410 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110516 |
Package Information of Budesonide
| Package NDC: | 0378-7155-01 |
| Package Description: | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-7155-01) |
NDC Information of Budesonide
| NDC Code | 0378-7155-01 |
| Proprietary Name | Budesonide |
| Package Description | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-7155-01) |
| Product NDC | 0378-7155 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | budesonide |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20110516 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | BUDESONIDE |
| Strength Number | 3 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
